PZOO logo

Pazoo, Inc. (PZOO) Análisis de Acciones

Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Cotizando a $, Pazoo, Inc. (PZOO) es una empresa del sector Healthcare valorada en 0. Calificado con 42/100 (cauteloso) en potencial de crecimiento, salud financiera e impulso.

Ultimo analisis: 16 mar 2026
Puntuación de IA de 42/100

Pazoo, Inc. (PZOO) Resumen de Asistencia Médica y Tuberías

CEOSteven Basloe
Sede CentralEast Hanover, US
Año de la oferta pública inicial (OPI)2012

Pazoo, Inc. is a health and wellness company specializing in laboratory testing services for the marijuana industry. Founded in 2010 and based in East Hanover, New Jersey, Pazoo operates within the specialty and generic drug manufacturing sector, focusing on a niche market within the broader healthcare landscape.

Procedencia de los datos | Datos financieros Análisis cuantitativo NASDAQ Análisis: 16 mar 2026

Tesis de Inversión

Pazoo, Inc. presents a speculative investment opportunity within the niche market of marijuana testing services. The company's focus on ensuring the safety and quality of cannabis products aligns with the increasing regulatory scrutiny and consumer demand for transparency in the industry. However, with a market capitalization of $0.00B and a negative P/E ratio, the company's financial performance requires careful evaluation. The growth of the legal cannabis market serves as a primary catalyst for Pazoo, driving demand for its testing services. However, the company faces potential risks associated with intense competition, evolving regulations, and the inherent volatility of the OTC market. Investors should conduct thorough due diligence and assess Pazoo's ability to scale its operations and achieve profitability in a rapidly changing landscape.

Basado en las finanzas de FMP y el análisis cuantitativo

Puntos clave

  • Pazoo, Inc. operates in the health and wellness sector, specifically providing laboratory testing services for marijuana.
  • The company was founded in 2010 and is headquartered in East Hanover, New Jersey.
  • Pazoo, Inc. was formerly known as IUCSS, Inc. and changed its name in May 2011.
  • The company's market capitalization is $0.00B.
  • Pazoo, Inc. has a beta of -14.70, indicating high volatility relative to the market.

Competidores y Pares

Fortalezas

  • Specialized focus on marijuana testing services.
  • Established presence in the cannabis industry.
  • Expertise in regulatory compliance.
  • Potential for growth in the expanding cannabis market.

Debilidades

  • Limited financial resources.
  • Dependence on the cannabis industry.
  • Small market capitalization.
  • Negative P/E ratio.

Catalizadores

  • Ongoing: Increasing legalization of marijuana across various states and countries, driving demand for testing services.
  • Ongoing: Growing awareness of the importance of quality control and regulatory compliance in the cannabis industry.
  • Ongoing: Potential partnerships with cannabis cultivators and manufacturers to expand market reach.

Riesgos

  • Potential: Intense competition from other testing laboratories.
  • Potential: Evolving regulatory landscape could impact testing requirements and costs.
  • Potential: Fluctuations in the cannabis market could affect demand for testing services.
  • Ongoing: Limited financial resources and small market capitalization.
  • Ongoing: Dependence on the cannabis industry.

Oportunidades de crecimiento

  • Expansion into New Geographic Markets: As more states and countries legalize marijuana, Pazoo has the opportunity to expand its testing services into new geographic markets. This expansion could involve establishing new laboratory facilities or partnering with existing labs to offer its services in different regions. The global cannabis testing market is projected to reach $2.5 billion by 2027, providing a significant growth opportunity for Pazoo. Timeline: Ongoing.
  • Development of New Testing Methodologies: Pazoo can invest in research and development to develop new and innovative testing methodologies for marijuana products. This could include developing more efficient and cost-effective testing methods, as well as expanding its testing capabilities to include new contaminants and compounds. The demand for advanced testing solutions is expected to increase as the cannabis industry matures. Timeline: Ongoing.
  • Partnerships with Cannabis Cultivators and Manufacturers: Pazoo can establish strategic partnerships with cannabis cultivators and manufacturers to become their preferred testing provider. These partnerships could involve offering discounted testing services or providing on-site testing capabilities. By building strong relationships with key players in the cannabis industry, Pazoo can secure a steady stream of revenue and expand its market share. Timeline: Ongoing.
  • Offering Consulting Services: In addition to testing services, Pazoo can offer consulting services to cannabis cultivators and manufacturers to help them comply with regulatory requirements and implement best practices for quality control. This could include providing guidance on cultivation techniques, manufacturing processes, and labeling requirements. The demand for consulting services is expected to increase as the cannabis industry becomes more regulated. Timeline: Ongoing.
  • Acquisition of Smaller Testing Labs: Pazoo can pursue a strategy of acquiring smaller testing labs to expand its market share and geographic reach. This could involve acquiring labs that specialize in specific types of testing or that are located in key geographic markets. By consolidating the cannabis testing industry, Pazoo can achieve economies of scale and increase its profitability. Timeline: Ongoing.

Oportunidades

  • Expansion into new geographic markets.
  • Development of new testing methodologies.
  • Partnerships with cannabis cultivators and manufacturers.
  • Offering consulting services.

Amenazas

  • Intense competition from other testing laboratories.
  • Evolving regulatory landscape.
  • Fluctuations in the cannabis market.
  • Potential for negative publicity.

Ventajas competitivas

  • Specialized expertise in marijuana testing.
  • Focus on regulatory compliance.
  • Established relationships with cannabis industry stakeholders.

Acerca de PZOO

Pazoo, Inc., established in 2010, is a health and wellness company that focuses on providing laboratory testing services for the marijuana industry. Originally named IUCSS, Inc., the company rebranded as Pazoo, Inc. in May 2011, signaling a strategic shift towards the burgeoning cannabis market. Headquartered in East Hanover, New Jersey, Pazoo aims to cater to the growing demand for quality assurance and regulatory compliance within the marijuana sector. Pazoo's core business revolves around offering testing services that ensure the safety, potency, and purity of marijuana products. These services are crucial for cultivators, manufacturers, and distributors looking to meet stringent regulatory requirements and consumer expectations. By providing accurate and reliable testing, Pazoo supports the integrity of the cannabis supply chain and helps build trust among consumers. As the legal cannabis market expands across various states, Pazoo is positioned to capitalize on the increasing need for standardized testing protocols. The company's services include analyzing cannabinoid profiles, detecting contaminants such as pesticides and heavy metals, and assessing the overall quality of marijuana products. Pazoo's commitment to scientific rigor and regulatory compliance underscores its role as a key player in the evolving cannabis industry.

Qué hacen

  • Provides laboratory testing services for marijuana.
  • Ensures the safety, potency, and purity of cannabis products.
  • Analyzes cannabinoid profiles.
  • Detects contaminants such as pesticides and heavy metals.
  • Assesses the overall quality of marijuana products.
  • Supports regulatory compliance for cannabis cultivators, manufacturers, and distributors.

Modelo de Negocio

  • Generates revenue by charging fees for laboratory testing services.
  • Offers testing services to cannabis cultivators, manufacturers, and distributors.
  • Focuses on providing accurate and reliable testing results.

Contexto de la Industria

Pazoo, Inc. operates within the Drug Manufacturers - Specialty & Generic industry, a segment of the broader healthcare sector. The market for cannabis testing services is growing rapidly, driven by the increasing legalization of marijuana across various states and countries. This growth is fueled by the need for quality control and regulatory compliance in the cannabis industry. Pazoo faces competition from other testing laboratories and analytical service providers. The company's success depends on its ability to provide accurate, reliable, and cost-effective testing solutions to cannabis cultivators, manufacturers, and distributors.

Clientes Clave

  • Cannabis cultivators
  • Cannabis manufacturers
  • Cannabis distributors
Confianza de la IA: 69% Actualizado: 16 mar 2026

Finanzas

Gráfico e información

Precio de la acción de Pazoo, Inc. (PZOO): Price data unavailable

Últimas noticias

No hay noticias recientes disponibles para PZOO.

Consenso de analistas

Calificación de Consenso

Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para PZOO.

Objetivos de Precios

Análisis del precio objetivo de Wall Street para PZOO.

MoonshotScore

42/100

¿Qué significa esta puntuación?

El MoonshotScore califica el potencial de crecimiento de PZOO en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.

Liderazgo: Steven Basloe

CEO

Steven Basloe serves as the CEO of Pazoo, Inc. Information regarding his detailed career history, educational background, and previous roles is not available in the provided data. Further research would be required to provide a comprehensive profile of Mr. Basloe's professional background and qualifications.

Historial: Due to the limited information available, it is not possible to assess Steven Basloe's track record at Pazoo, Inc. Key achievements, strategic decisions, and company milestones under his leadership cannot be determined without additional data.

Información del mercado OTC de PZOO

The OTC Other tier represents the lowest tier of the OTC market, encompassing stocks that may not meet the minimum financial standards or have chosen not to comply with the reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited information available to investors and may be subject to less regulatory oversight compared to those listed on major exchanges like the NYSE or NASDAQ. Investing in OTC Other stocks carries a higher degree of risk due to the potential for fraud, lack of transparency, and limited liquidity.

  • Nivel OTC: OTC Other
  • Estado de divulgación: Unknown
Liquidez: Liquidity for PZOO shares on the OTC market is likely to be limited, given its classification in the OTC Other tier. This can result in wide bid-ask spreads, making it challenging to buy or sell shares at desired prices. Low trading volumes can also exacerbate price volatility and increase the risk of significant losses for investors.
Factores de riesgo OTC:
  • Limited financial disclosure and transparency.
  • Potential for fraud and market manipulation.
  • High price volatility due to low trading volume.
  • Limited liquidity, making it difficult to buy or sell shares.
  • Lack of regulatory oversight compared to major exchanges.
Lista de verificación de diligencia debida:
  • Verify the company's registration and legal standing.
  • Obtain and review any available financial statements.
  • Assess the company's business model and competitive landscape.
  • Evaluate the management team's experience and track record.
  • Understand the risks associated with investing in OTC stocks.
  • Consult with a financial advisor before making any investment decisions.
Señales de legitimidad:
  • Company has been in operation since 2010.
  • Focuses on laboratory testing services for the marijuana industry, which aligns with a growing market.
  • Headquartered in East Hanover, New Jersey.

Preguntas Comunes Sobre PZOO

¿Cuáles son los factores clave para evaluar PZOO?

Pazoo, Inc. (PZOO) actualmente tiene una puntuación IA de 42/100, indicando puntuación baja. Fortaleza clave: Specialized focus on marijuana testing services.. Riesgo principal a monitorear: Potential: Intense competition from other testing laboratories.. Esto no es asesoramiento financiero.

¿Qué es el MoonshotScore de PZOO?

PZOO actualmente puntúa 42/100 (Grado D) en el MoonshotScore, lo que sugiere calificación baja. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.

¿Con qué frecuencia se actualizan los datos de PZOO?

Los precios de PZOO se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.

¿Qué dicen los analistas sobre PZOO?

La cobertura de analistas para PZOO incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.

¿Cuáles son los riesgos de invertir en PZOO?

Las categorías de riesgo para PZOO incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Intense competition from other testing laboratories.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.

¿Cuál es la relación P/E de PZOO?

La relación P/E para PZOO compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.

¿Está PZOO sobrevalorada o infravalorada?

Determinar si Pazoo, Inc. (PZOO) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.

¿Cuál es el rendimiento por dividendo de PZOO?

Pazoo, Inc. (PZOO) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.

Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.

Recursos Oficiales

Análisis actualizado el Puntuación de IA actualizada diariamente
Fuentes de Datos y Metodología
Datos de mercado proporcionados por Financial Modeling Prep y Yahoo Finance. Análisis de IA por algoritmos propietarios de Stock Expert AI. Indicadores técnicos mediante cálculos estándar de la industria. Última actualización: .

Datos proporcionados solo con fines informativos.

Notas de análisis
  • Limited financial data available for Pazoo, Inc.
  • OTC market investments carry higher risk.
Fuentes de datos

Popular Stocks